The only stem cell study combining two proven delivery approaches for bone marrow-derived stem cells to the central and peripheral nervous systems. Multiple neurologic conditions are eligible, but the largest categories include chronic Stroke (CVA), Parkinson’s Disease, Traumatic Brain Injury, Multiple Sclerosis, and Peripheral Neuropathy. Our initial patients with Parkinson’s have reported improvements following treatment including balance, facial musculature, loss of mask appearance, fine muscle control, posture, gate and speed of walking, reduced fatigue and depression, improvement in sleep.